Dermira (DERM) Tops Q3 EPS by $1.15

Dermira (NASDAQ: DERM) reported Q3 EPS of $0.99, $1.15 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $34.54 million versus the consensus estimate of $16.9 million.

For earnings history and earnings-related data on Dermira (DERM) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Borr Drilling (BORR) Misses Q2 EPS by 69c
• Mount Logan Capital Inc. (MLCI) Reports Q2 Loss of $0.37